Tag: pulmonary embolism (pe)

Thrombosis With Thrombocytopenia After mRNA COVID-19 Vaccine

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. What is believed to be the first case of thrombosis with...

Tofacitinib Linked to Risk for Cardiac Events, Cancer, FDA Warns

The Food and Drug Administration has alerted the public to an increased risk of serious heart-related problems and cancer risk associated with the Janus kinase...

Tofacitinib for RA Misses the Mark in Safety Study

Daily treatment with tofacitinib (Xeljanz) led to more malignancies and adverse cardiovascular events in older rheumatoid arthritis patients compared with treatment with a tumor necrosis...

COVID-19 and Risk of Clotting: ‘Be Proactive About Prevention’

The risk of arterial and venous thrombosis in patients with COVID-19 has been a major issue throughout the pandemic, and how best to manage this...

Clopidogrel Bests Ticagrelor for Elective PCI

Ticagrelor failed to unseat clopidogrel as the guideline-recommended P2Y12 inhibitor of choice in patients undergoing elective percutaneous coronary intervention for stable CAD in the randomized...

Researchers Say Aspirin May Help COVID Patients

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Researchers have known since the early days of the coronavirus pandemic...

New Data on Benefit, Risk for Anticoagulation in COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Two studies from New York City, the early epicenter of the...

Finer Risk Stratification Key in Acute Pulmonary Embolism

All intermediate-risk pulmonary embolism is not the same, Victor F. Tapson, MD, declared at the virtual annual conference of the Society of Hospital Medicine. The...

COVID-19 Update: Conspiracy Theories, Cutaneous Clues

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Here are the coronavirus stories Medscape’s editors around the globe think...

Cautions Raised Against Off-Label DOACs to Clear LV Thrombi

The newer class of oral anticoagulants that have been supplanting the traditional mainstay warfarin for a variety of indications may be inferior for at least...

ESC Guidance on CVD Diagnosis, Management Amid COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s  Coronavirus Resource Center. The European Society of Cardiology (ESC) has issued guidance on the...

New Classification Urged for PFO-Associated Stroke

A call has been made for a new classification of ischemic stroke for patients who have a patent foramen ovale (PFO) that is thought to...

Edoxaban Noninferior to Warfarin After Valve Surgery?

The first randomized trial comparing a direct oral anticoagulant (DOAC) with warfarin after surgical bioprosthetic valve replacement has suggested noninferiority of edoxaban (Savaysa, Daiichi Sankyo)...